Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon β1a
Frederik Barkhof(National Hospital for Neurology and Neurosurgery), Massimo Filippi(Vita-Salute San Raffaele University), Bernard M.J. Uitdehaag(Amsterdam Neuroscience), Óscar Fernández(Universidad de Málaga), Gıancarlo Comı(Casa di Cura Columbus), O. R. Hommes, Marco Rovaris(San Raffaele University of Rome), Hans‐Peter Hartung(The University of Sydney), Per Soelberg Sørensen(University of Copenhagen), Luca Durelli(University of Turin), Gilles Edan(Centre National de la Recherche Scientifique), Maria A. Rocca(Vita-Salute San Raffaele University), Pierette Seeldrayers(Erasmus Hospital), Jan‐Hein T. M. van Waesberghe(Cancer Center Amsterdam), S. Margrie(Westmead Hospital), Gordon Francis(Ono Pharmaceutical (United States))
Cited by 135
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k